LLY
Eli Lilly and Company

Eli Lilly and CompanyLLY

0.00USD
Change unavailable
Nov 08, 2026
LLY overview ready
Price
Loading price history…

Price Action

Mature

Key Financials

Revenue Growth YoY
+44.7%
FY2025 vs FY2024
Financial results for the period ended Sep 30, 2026
Filed balance-sheet data as of Sep 30, 2026

Business Performance

Decelerating

Revenue is still growing (+39% YoY), but growth has slowed for 2 consecutive quarters, down from +56%. Diluted EPS is up 16% year over year ($7.22), but growth has slowed from +170%.

Latest reported: Q3 FY2026, ended Sep 30
Revenue growthSlowing
+39%
$24.4B in Q3 FY2026 · YoY
YoY growth, last 4 quarters
  1. +43%
  2. +56%
  3. +48%
  4. +39%
Earnings growthSlowing
+16%
Diluted EPS $7.22 vs $6.21 a year earlier · GAAP
Diluted EPS YoY (GAAP), last 4 quarters
  1. +51%
  2. +170%
  3. +26%
  4. +16%
Operating marginNot enough data
—
No year-ago comparison

Business Quality

8.2 / 10

How well the business earns on its assets, converts earnings to cash and funds itself — read from its SEC filings.

Fundamentals & Valuation

No valuation has been published for this company yet.

Company Research

Research coverage for this company is in progress.

Economic classification

Loading the economic classification…

Business & Markets

No company profile has been published for this ticker yet.